Apollo Hospitals Enterprise is currently trading at Rs. 5010.60, up by 47.15 points or 0.95% from its previous closing of Rs. 4963.45 on the BSE.
The scrip opened at Rs. 4951.00 and has touched a high and low of Rs. 5137.10 and Rs. 4924.05 respectively. So far 12242 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 5930.70 on 26-Nov-2021 and a 52 week low of Rs. 2386.25 on 05-Jan-2021.
Last one week high and low of the scrip stood at Rs. 5137.10 and Rs. 4908.00 respectively. The current market cap of the company is Rs. 72611.25 crore.
The promoters holding in the company stood at 29.82%, while Institutions and Non-Institutions held 64.05% and 6.08% respectively.
Apollo Hospitals has launched the vaccination programme for children aged 15-18 years at its vaccination centres across the country. The vaccine administered would be Covaxin, which has received emergency use approval for use in children by the Drugs Controller General of India (DCGI).
Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, etc.